Jessica Marlin is a Virginia native who moved to Nashville, TN in 2001. After studying medical sciences, in 2005 she began her career in clinical research by working as a coordinator for breast cancer drug and device trials.  She obtained hands on experience working on 20+ treatment and device trials while managing IRB responsibilities, patient care, assessing patients in clinic, assisting with tumor extraction in the OR, data collection, drug accountability, and treatment.  Her role grew to include expanding the research team to multiple surgeons, radiologists, and oncologists in order to enhance recruitment capabilities and the knowledge of research options for patients.

In December 2007, Jessica’s passion for working to provide better treatment options for cancer patients led her to a study management position at the Sarah Cannon Research Institute (SCRI) in Nashville, TN.  In this role, she managed multi-center breast, lung, head and neck, unknown primary, and outcomes trials for oncology research.  While at SCRI, Jessica had the opportunity to work on statistical analyses and was published for two of the breast cancer trials in which she worked.  Her clinical experience gave her the unique opportunity of assisting sites with recruitment strategies while helping to oversee daily research activities and compliance.  As Jessica further developed her site relationships, in 2010 she was offered the opportunity to move into a site relationship management position and to spearhead the AskSARAH initiative that would provide better research related customer service options to all sites.  As part of this role, she managed site selection and trial start up for all SCRI Investigator Initiated trials.

Jessica is currently working at Vanderbilt University as part of the Vanderbilt Coordinating Center (VCC).  She began her role at Vanderbilt in 2013 by overseeing sponsor, site and patient care responsibilities for multiple stroke and aneurysm treatment and device trials.  Her diverse research experience along with her knowledge of FDA/GCP guidances and regulations afforded her the opportunity of multi-center clinical trial project oversight for investigator initiated and industry sponsored trials, as well as, research and development within multiple surgical and medical departments at Vanderbilt.  In 2016, she became part of the leadership team spearheading the Vanderbilt Coordinating Center.  Her role has included management of one of the Local Support Services teams of research coordinators and now encompasses study start up and clinical trials operations management for multi-center projects.